We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-cola Euro. Regulatory News (CCEP)

Share Price Information for Coca-cola Euro. (CCEP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 67.20
Bid: 66.80
Ask: 67.00
Change: -0.20 (-0.30%)
Spread: 0.20 (0.299%)
Open: 67.20
High: 67.40
Low: 66.20
Prev. Close: 67.40
CCEP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

14 Dec 2023 11:00

RNS Number : 8350W
Coca-Cola Europacific Partners plc
14 December 2023
 

COCA-COLA EUROPACIFIC PARTNERS PLC

 

BOARD AND COMMITTEE CHANGES

 

Coca-Cola Europacific Partners plc (CCEP) announces that Garry Watts has resigned from the Board with effect from 31 December 2023. As part of the Board's succession planning and following a comprehensive search and selection process, the Board has approved the appointment of Guillaume Bacuvier as a new Independent Non-executive Director to succeed Garry, which was approved by the Board on 13 December 2023. Guillaume's appointment will be effective from 1 January 2024.

 

Garry Watts was appointed as a Non-executive Director of CCEP in April 2016, having previously been a director of Coca-Cola Enterprises Inc ("CCE") since 2010. He served as Chairman of the Audit Committee from April 2016 until May 2022 and has remained a member of the Committee to date. Garry was previously a member of the Remuneration Committee from April 2016 until October 2021 and has also been a member of the Affiliated Transaction Committee since October 2021. His extensive financial and business experience in Western Europe and particularly the UK has been invaluable to the Board since the merger. The Board would also like to recognise the contribution Garry has played in shaping the success of CCEP to date.

 

As part of the changes, effective 1 January 2024 Nicolas Mirzayantz will become a member of the Audit Committee.

 

About Guillaume Bacuvier

 

Guillaume Bacuvier brings to the Board valuable perspectives on consumer behaviors and strategy, as well as marketing effectiveness insights from across Europe and APAC obtained through his consulting work. Guillaume is currently the CEO of Worldpanel, Kantar's consumer panel market research division, where he is leading the transformation of the company's operating model and technology environment. He also serves as a Non-executive Director of Berger-Levrault a mid-cap software business. Guillaume was previously the CEO of Dunnhumby and held a number of senior positions at Google and Orange, as well as Non-executive directorships with Attest and VEON.

  

Sol Daurella, Chairman said, "Garry has made a huge contribution from the very beginning of CCEP and has been instrumental in our success. We wish him every success for the future. I would also like to welcome Guillaume to the Board and I look forward to working with him and the rest of the Board."

 

This announcement is made pursuant to LR 9.6.11R of the Listing Rules.

 

There is no further information required to be notified under Listing Rule 9.6.13R with regard to Guillaume Bacuvier's appointment referred to above. 

 

 

 

 

 

 

 

 

CONTACTS

 

Company Secretariat

Clare Wardle

T +44 20 7355 8406

Investor Relations

Sarah Willett

+44 7970 145 218

Media Relations

Shanna Wendt

T +44 7976 595 168

 

ABOUT CCEP

 

CCEP is one of the leading consumer goods companies in the world. We make, move and sell some the world's most loved brands - serving 600 million consumers and helping 2 million customers across 30 countries grow their business. We combine the strength and scale of a large, multi-national business with an expert, local knowledge of the customers we serve and communities we support. The Company is currently listed on Euronext Amsterdam, the NASDAQ Global Select Market, London Stock Exchange and on the Spanish Stock Exchanges, trading under the symbol CCEP. For more information about CCEP, please visit www.cocacolaep.com & follow CCEP on Twitter at @CocaColaEP.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFIFSAFLLSLIV
Date   Source Headline
25th Apr 20247:00 amRNSQ1 Trading Update & Interim Dividend Declaration
24th Apr 20241:30 pmRNSDirector/PDMR Shareholding
17th Apr 20241:45 pmRNSDirector/PDMR Shareholding
10th Apr 20249:15 amRNSNotice of AGM
2nd Apr 20242:30 pmRNSTotal Voting Rights
21st Mar 20242:00 pmRNSDirector/PDMR Shareholding
20th Mar 20243:00 pmRNSDirector/PDMR Shareholding
18th Mar 20244:30 pmRNSBlock listing Interim Review
15th Mar 202411:59 amRNSAnnual Financial Report
1st Mar 20242:00 pmRNSTotal Voting Rights
23rd Feb 20247:00 amRNSCompletion of joint acquisition of CCBPI
23rd Feb 20247:00 amRNSPreliminary Unaudited Results Q4 & FY 2023
21st Feb 20245:00 pmRNSDirector/PDMR Shareholding
1st Feb 20242:30 pmRNSTotal Voting Rights
30th Jan 202411:30 amRNSPCC approval received to jointly acquire CCBPI
26th Jan 20244:15 pmRNSDirector/PDMR Shareholding - amendment
25th Jan 202410:30 amRNSDirector/PDMR Shareholding
22nd Jan 20243:15 pmRNSDirector/PDMR Shareholding
17th Jan 202411:30 amRNSDirector/PDMR Shareholding
2nd Jan 20241:30 pmRNSTotal Voting Rights
20th Dec 202311:15 amRNSDirector/PDMR Shareholding
18th Dec 202312:15 pmRNSDirector/PDMR Shareholding
15th Dec 20233:40 pmRNSDirector/PDMR Shareholding
14th Dec 202311:00 amRNSDirectorate Change
1st Dec 20231:45 pmRNSTotal Voting Rights
28th Nov 20234:00 pmRNSDirector/PDMR Shareholding
24th Nov 20232:30 pmRNSUpdate statement on 2023 AGM voting results
21st Nov 20234:30 pmRNSDirector/PDMR Shareholding
20th Nov 20237:00 amRNSUpdate re acquisition of CCBPI
1st Nov 20231:45 pmRNSTotal Voting Rights
1st Nov 20237:00 amRNSQ3 Trading Update & Interim Dividend Declaration
25th Oct 20231:30 pmRNSDirector/PDMR Shareholding
20th Oct 202312:00 pmRNSDirector/PDMR Shareholding
13th Oct 20232:30 pmRNSDirector/PDMR Shareholding
20th Sep 20234:45 pmRNSDirector/PDMR Shareholding
18th Sep 20234:50 pmRNSBlock listing Interim Review
1st Sep 20231:30 pmRNSTotal Voting Rights
22nd Aug 20233:00 pmRNSDirector/PDMR Shareholding
2nd Aug 20237:01 amRNSResults for the six months ended 30 June 2023
2nd Aug 20237:00 amRNSProposed joint acquisition of CCBPI
1st Aug 20231:05 pmRNSTotal Voting Rights
25th Jul 20234:00 pmRNSDirector/PDMR Shareholding
21st Jul 20232:30 pmRNSDirector/PDMR Shareholding
13th Jul 20233:30 pmRNSDirector/PDMR Shareholding
30th Jun 20234:30 pmRNSDirector/PDMR Shareholding
23rd Jun 20233:00 pmRNSDirector/PDMR Shareholding
8th Jun 202310:50 amRNSDirector/PDMR Shareholding
1st Jun 20232:15 pmRNSTotal Voting Rights
26th May 20234:30 pmRNSDirector/PDMR Shareholding
25th May 202311:30 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.